A subset of circulating microRNAs are predictive for cardiac death after discharge for acute myocardial infarction

Biochemical and Biophysical Research Communications

Volumn 427, Issue 2, 2012, Pages 280-284

  Matsumoto, Sen ^a   Sakata, Yasuhiko ^a,b   Nakatani, Daisaku ^a   Suna, Shinichiro ^a   Mizuno, Hiroya ^a   Shimizu, Masahiko ^a   Usami, Masaya ^a   Sasaki, Tatsuya ^c   Sato, Hiroshi ^d   Kawahara, Yukio ^a   Hamasaki, Toshimitsu ^a   Nanto, Shinsuke ^a   Hori, Masatsugu ^e   Komuro, Issei ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c MINAMI OSAKA GENERAL HOSPITAL   (Japan)

^d KWANSEI GAKUIN UNIVERSITY   (Japan)

^e OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Acute myocardial infarction; Circulating microRNAs; Secondary prevention

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MICRORNA; MICRORNA 155; MICRORNA 380; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; AGED; ARTICLE; BLOOD SAMPLING; FEMALE; HEART DEATH; HIGH RISK PATIENT; HIGH THROUGHPUT SCREENING; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; SURVIVAL RATE;

AGED; BIOLOGICAL MARKERS; DEATH; FEMALE; HUMANS; MALE; MICRORNAS; MYOCARDIAL INFARCTION; PATIENT DISCHARGE; PROGNOSIS;

EID: 84867870687     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.09.039     Document Type: Article

References (14)

1. D'Alessandra Y., Devanna P., Limana F., et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur. Heart. J. 2010, 31:2765-2773.
2. Lawrie C.H., Gal S., Dunlop H.M., et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol. 2008, 141:672-675.
3. Wang G.K., Zhu J.Q., Zhang J.T., et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur. Heart. J. 2010, 31:659-666.
4. Metz C.E. Basic principles of ROC analysis. Semin. Nucl. Med. 1978, 8:283-298.
5. Kuwabara Y., Ono K., Horie T., et al. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ. Cardiovasc. Genet. 2011, 4:446-454.
6. Sakata Y., Nakatani D., Shimizu M., et al. Oral treatment with nicorandil at discharge is associated with reduced mortality after acute myocardial infarction. J. Cardiol. 2012, 59:14-21.
7. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
8. Ueda T., Volinia S., Okumura H., et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet. Oncol. 2010, 11:136-146.
9. Mitchell P.S., Parkin R.K., Kroh E.M., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Nat. Acad. Sci. USA 2008, 105:10513-10518.
10. Liu C., Kelnar K., Liu B., et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat. Med. 2011, 17:211-215.
11. Martin M.M., Lee E.J., Buckenberger J.A., et al. MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. J. Biol. Chem. 2006, 281:18277-18284.
12. Yao R., Ma Y., Du Y., et al. The altered expression of inflammation-related microRNAs with microRNA-155 expression correlates with Th17 differentiation in patients with acute coronary syndrome. Cell. Mol. Immunol. 2011, 8:486-495.
13. Swarbrick A., Woods S.L., Shaw A., et al. MiR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma. Nat. Med. 2010, 16:1134-1140.
14. Sano M., Minamino T., Toko H., et al. P53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 2007, 446:444-448.